This is the third GLP-1 medication to be approved in pill form this year
While this effect has been primarily observed in the GI tract, there is evidence for similar benefit in cardiovascular, neurological, and muscle tissues, suggesting that BPC-157 may be used as both a therapy in the setting of stroke and heart attack as well as a probative peptide for understanding how to promote healing following ischemic injury [5], [6]
Many patients discontinue GLP-1 medications due to cost or side effects like nausea and fatigue
We cover the specifics in Is Compounded Semaglutide Still Legal in 2026
When Microdosing Is Not Appropriate Microdosing has a place, but it is not the right choice for every patient
Most patients need testing every 3-6 months during active treatment, with baseline testing before starting medications (American Diabetes Association 2025)